CELC
Price
$93.32
Change
+$0.88 (+0.95%)
Updated
Aug 18, 04:59 PM (EDT)
Capitalization
4.53B
92 days until earnings call
Intraday BUY SELL Signals
IMVT
Price
$44.35
Change
+$0.64 (+1.46%)
Updated
Aug 18, 04:59 PM (EDT)
Capitalization
9.03B
92 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CELC vs IMVT

CELC vs IMVT Comparison Chart in %
View a ticker or compare two or three
VS
CELC vs. IMVT commentary
Aug 19, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CELC is a Hold and IMVT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 19, 2026
Stock price -- (CELC: $92.44 vs. IMVT: $43.71)
Brand notoriety: CELC and IMVT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CELC: 44% vs. IMVT: 68%
Market capitalization -- CELC: $4.53B vs. IMVT: $9.03B
CELC [@Biotechnology] is valued at $4.53B. IMVT’s [@Biotechnology] market capitalization is $9.03B. The market cap for tickers in the [@Biotechnology] industry ranges from $130.67B to $0. The average market capitalization across the [@Biotechnology] industry is $2.26B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CELC’s FA Score shows that 0 FA rating(s) are green whileIMVT’s FA Score has 0 green FA rating(s).

  • CELC’s FA Score: 0 green, 5 red.
  • IMVT’s FA Score: 0 green, 5 red.
According to our system of comparison, IMVT is a better buy in the long-term than CELC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CELC’s TA Score shows that 4 TA indicator(s) are bullish while IMVT’s TA Score has 4 bullish TA indicator(s).

  • CELC’s TA Score: 4 bullish, 4 bearish.
  • IMVT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both CELC and IMVT are a good buy in the short-term.

Price Growth

CELC (@Biotechnology) experienced а +1.82% price change this week, while IMVT (@Biotechnology) price change was +9.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.82%. For the same industry, the average monthly price growth was +0.85%, and the average quarterly price growth was +2906.74%.

Reported Earning Dates

CELC is expected to report earnings on Nov 18, 2026.

IMVT is expected to report earnings on Nov 18, 2026.

Industries' Descriptions

@Biotechnology (+0.82% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMVT($9.03B) has a higher market cap than CELC($4.53B). IMVT YTD gains are higher at: 71.951 vs. CELC (-7.319). CELC has higher annual earnings (EBITDA): -172.66M vs. IMVT (-532.49M). IMVT has more cash in the bank: 902M vs. CELC (387M). IMVT has less debt than CELC: IMVT (72K) vs CELC (323M). CELC (0) and IMVT (0) have equivalent revenues.
CELCIMVTCELC / IMVT
Capitalization4.53B9.03B50%
EBITDA-172.66M-532.49M32%
Gain YTD-7.31971.951-10%
P/E RatioN/AN/A-
Revenue00-
Total Cash387M902M43%
Total Debt323M72K448,611%
FUNDAMENTALS RATINGS
CELC vs IMVT: Fundamental Ratings
CELC
IMVT
OUTLOOK RATING
1..100
1613
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
53
Fair valued
PROFIT vs RISK RATING
1..100
4548
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
5836
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMVT's Valuation (53) in the null industry is in the same range as CELC (82) in the Miscellaneous Commercial Services industry. This means that IMVT’s stock grew similarly to CELC’s over the last 12 months.

CELC's Profit vs Risk Rating (45) in the Miscellaneous Commercial Services industry is in the same range as IMVT (48) in the null industry. This means that CELC’s stock grew similarly to IMVT’s over the last 12 months.

IMVT's SMR Rating (99) in the null industry is in the same range as CELC (100) in the Miscellaneous Commercial Services industry. This means that IMVT’s stock grew similarly to CELC’s over the last 12 months.

IMVT's Price Growth Rating (36) in the null industry is in the same range as CELC (58) in the Miscellaneous Commercial Services industry. This means that IMVT’s stock grew similarly to CELC’s over the last 12 months.

IMVT's P/E Growth Rating (100) in the null industry is in the same range as CELC (100) in the Miscellaneous Commercial Services industry. This means that IMVT’s stock grew similarly to CELC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CELCIMVT
RSI
ODDS (%)
N/A
Bearish Trend 5 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 5 days ago
86%
Momentum
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 5 days ago
78%
MACD
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 5 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
84%
Bullish Trend 5 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 5 days ago
82%
Advances
ODDS (%)
Bullish Trend 14 days ago
83%
Bullish Trend 7 days ago
77%
Declines
ODDS (%)
Bearish Trend 8 days ago
84%
Bearish Trend 16 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
87%
Bearish Trend 5 days ago
89%
Aroon
ODDS (%)
Bearish Trend 5 days ago
83%
Bullish Trend 5 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CELC
Daily Signal:
Gain/Loss:
IMVT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BPYPP16.280.09
+0.56%
Brookfield Property Partners LP
TIL7.36-0.02
-0.27%
Instil Bio
DHC8.29-0.09
-1.07%
Diversified Healthcare Trust
FPS38.83-0.83
-2.09%
Forgent Power Solutions Inc
ELVA7.70-0.25
-3.14%
Electrovaya

CELC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CELC has been closely correlated with IMA. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if CELC jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELC
1D Price
Change %
CELC100%
+0.48%
IMA - CELC
76%
Closely correlated
-4.45%
SLXN - CELC
50%
Loosely correlated
+0.43%
ABOS - CELC
44%
Loosely correlated
-0.37%
GLSI - CELC
39%
Loosely correlated
+3.45%
IMVT - CELC
38%
Loosely correlated
+4.52%
More